Worldwide Clinical Trials
Stephen Grayauskie is a seasoned finance professional with extensive experience in financial planning and analysis, management, and budgeting across multiple industries including clinical trials, health sciences, technology, and finance. Currently serving as Senior Manager - Global FP&A at Worldwide Clinical Trials, responsibilities include coordinating the annual budget process and analyzing cost drivers. Previous roles include Manager - Operations Finance at PRA Health Sciences, where Stephen mentored a team and prepared annual budgets, and Finance Manager at Unisys, contributing to revenue and cost opportunities in customer engagements. A strong background in financial analysis is demonstrated through positions at FIS, Frontline Education, and Interline Brands, showcasing expertise in financial reporting, variance analysis, and budgeting processes. Stephen holds a BBA in Accounting from the Fox School of Business at Temple University.
This person is not in any teams
This person is not in any offices
Worldwide Clinical Trials
11 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.